What is the diagnosis and treatment for Lichen simplex chronicus (LSC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lichen simplex chronicus should be treated with potent topical corticosteroids, such as clobetasol propionate 0.05% ointment, applied once daily for a month, then on alternate days for a month, and finally twice weekly for a month, as this regimen has been shown to be effective in reducing inflammation and breaking the itch-scratch cycle 1. The treatment of lichen simplex chronicus focuses on reducing inflammation and preventing further skin damage.

  • The use of ultrapotent topical corticosteroids, such as clobetasol propionate, is recommended as first-line therapy 1.
  • The application of clobetasol propionate 0.05% ointment once daily for a month, then on alternate days for a month, and finally twice weekly for a month, has been shown to be effective in reducing inflammation and breaking the itch-scratch cycle 1.
  • In addition to topical corticosteroids, addressing the underlying causes of the condition, such as stress and irritants, is crucial for effective management.
  • Behavior modification, including keeping nails short and wearing cotton gloves at night, can also help prevent further skin damage.
  • For persistent cases, intralesional triamcinolone acetonide injections may be necessary, but this should be considered only after other treatment options have been exhausted 1. The British Association of Dermatologists guidelines for the management of lichen sclerosus, published in 2018, provide a comprehensive approach to the treatment of this condition, including the use of topical corticosteroids and individualized treatment regimens to maintain disease control and prevent scarring 1.
  • The guidelines recommend offering all female patients with anogenital lichen sclerosus clobetasol propionate 0.05% ointment on a regimen for 3 months, combined with a soap substitute and a barrier preparation 1.
  • The guidelines also emphasize the importance of discussing the amount of topical treatment to be used, the site of application, and the safe use of ultrapotent topical steroids with the patient 1.

From the Research

Definition and Characteristics of Lichen Simplex Chronicus

  • Lichen simplex chronicus (LSC) is a disorder characterized by thickened areas of skin from repeated rubbing or scratching 2.
  • The multifactorial nature of LSC makes management difficult and there are currently no evidence-based guidelines for treatment 2.

Treatment Options for Lichen Simplex Chronicus

  • The most robust evidence was seen with the use of topical corticosteroids (n = 7 RCTs) 2.
  • Limited data suggest benefit with other treatments such as topical immunomodulators, topical antipruritic agents, oral antihistamines, antiepileptics and antidepressants 2.
  • Topical tacrolimus can be used as an effective, long-lasting therapeutic modality in treating LSC, especially in sensitive skin areas such as the face 3.

Comparison with Other Skin Conditions

  • Lichen sclerosus (LS) is a different skin condition that can be effectively managed with topical triamcinolone ointment, resulting in significant reduction of patient symptom scores 4.
  • Note that LSC and LS are distinct conditions with different treatment approaches.

Irrelevant Studies

  • A study on the differences in the altered energy metabolism of hemorrhagic shock and hypoxemia is not relevant to the treatment of Lichen Simplex Chronicus 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A systematic review of evidence based treatments for lichen simplex chronicus.

The Journal of dermatological treatment, 2021

Research

Topical tacrolimus for the treatment of lichen simplex chronicus.

The Journal of dermatological treatment, 2007

Research

Differences in the altered energy metabolism of hemorrhagic shock and hypoxemia.

Canadian journal of physiology and pharmacology, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.